Relief Therapeutics Holding SA (ETR:RLF) | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

BRIEF

published on 11/25/2025 at 07:05, 10 days ago

Relief Therapeutics et NeuroX présentent leurs perspectives financières en vue de leur fusion

Marge D'EBITDA Perspectives Financières Thérapeutiques De Soulagement Fusion NeuroX Neurothérapie Numérique
BRIEF

published on 11/25/2025 at 07:05, 10 days ago

Relief Therapeutics and NeuroX Present Financial Outlook for Merger

EBITDA Margin Financial Outlook Relief Therapeutics NeuroX Merger Digital Neurotherapeutics
PRESS RELEASE

published on 11/25/2025 at 07:00, 10 days ago

Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics and NeuroX reveal joint presentation and financial outlook in anticipation of business combination. Financial guidance includes revenue projections and EBITDA margin targets

Business Combination Financial Outlook Relief Therapeutics Press Conference NeuroX
BRIEF

published on 11/14/2025 at 18:25, 20 days 13 hours ago

Relief Therapeutics Shareholders Approve Merger with NeuroX

Leadership Changes Shareholder Approval Capital Increase Relief Therapeutics NeuroX Merger
BRIEF

published on 11/14/2025 at 18:25, 20 days 13 hours ago

Les actionnaires de Relief Therapeutics approuvent la fusion avec NeuroX

Augmentation De Capital Approbation Des Actionnaires Thérapeutiques De Soulagement Fusion De NeuroX Changements De Leadership
PRESS RELEASE

published on 11/14/2025 at 18:20, 20 days 13 hours ago

Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Relief Therapeutics shareholders approve business combination with NeuroX, creating a digital neurotherapeutics company. New board members elected. Business combination expected to close in December 2025

Shareholders Business Combination Relief Therapeutics NeuroX Digital Neurotherapeutics
BRIEF

published on 10/29/2025 at 07:05, 1 month 7 days ago

Relief Therapeutics Reports Positive Outcomes in RLF-OD032 Study

FDA Approval RLF-OD032 Phenylketonuria Treatment Bioequivalence Study Sapropterin Dihydrochloride
BRIEF

published on 10/29/2025 at 07:05, 1 month 7 days ago

Relief Therapeutics annonce des résultats positifs dans l'étude RLF-OD032

Approbation De La FDA RLF-OD032 Traitement De La Phénylcétonurie Étude De Bioéquivalence Dichlorhydrate De Saproptérine
PRESS RELEASE

published on 10/29/2025 at 07:00, 1 month 7 days ago

Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
Relief Therapeutics announces positive results from pivotal bioequivalence study of RLF-OD032, demonstrating bioequivalence to KUVAN®, supporting NDA submission in early 2026

FDA Approval Relief Therapeutics RLF-OD032 Bioequivalence Study PKU Treatment
BRIEF

published on 10/24/2025 at 07:04, 1 month 12 days ago

Relief Therapeutics convoque une assemblée générale extraordinaire pour une fusion d'entreprises

Assemblée Générale Extraordinaire THÉRAPEUTIQUE DE SECOURS Regroupement D'entreprises MindMaze Therapeutics Groupe NeuroX

1 2 ... 9

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 54 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 59 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 29 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 24 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 29 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 29 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 59 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 38 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 4 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 14 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 14 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 29 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 29 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 44 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 44 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE